Clinical Trial Update: A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on BMS-986528 for refractory rheumatoid arthritis, a Phase 1/2 study sponsored by Bristol-Myers Squibb. The trial is currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BMS-986528

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Arthritis, Rheumatoid | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING